Strontium ranelate (Fujisawa/Servier).
Strontium ranelate (PROTELOS), a divalent strontium salt, has been developed and launched by Servier for the treatment of osteoporosis. Fujisawa Pharmaceutical is developing the drug in Japan; in November 2004, phase II Japanese trials were ongoing.
Jupsin
Isabelle
I
Bone and Cartilage Metabolism Research Unit. CHU Centre-Ville, Policliniques L Brull, Quai Godefroid Kurth 45, 4020 Liège, Belgium.
Collette
Julien
J
Henrotin
Yves
Y
Bruyere
Olivier
O
Sarlet
Nathalie
N
Reginster
Jean-Yves
JY
D000818:Animals; D001862:Bone Resorption / Q000188:drug therapy; D004345:Drug Industry / Q000191:economics / Q000379:methods; D005260:Female; D006801:Humans; D009942:Organometallic Compounds / Q000737:chemistry / Q000494:pharmacology / Q000627:therapeutic use*; D015663:Osteoporosis, Postmenopausal / Q000188:drug therapy / Q000453:epidemiology; D013876:Thiophenes / Q000737:chemistry / Q000494:pharmacology / Q000627:therapeutic use*
D009942:Organometallic Compounds; D013876:Thiophenes; C081587:strontium ranelate